{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:46:51Z","timestamp":1787683611895,"version":"build-2784847793"},"reference-count":28,"publisher":"The Endocrine Society","issue":"11","funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"The National Institute of Diabetes, and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Identification of tumors causing ectopic ACTH syndrome (EAS) is challenging. 68Ga-DOTATATE (DOTA) and 18F-DOPA (DOPA) positron emission tomography\/computed tomography (PET\/CT) scans are promising imaging modalities warranting further evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aimed to compare DOTA and DOPA PET\/CT performance in detecting ectopic sources of adrenocorticotropin (ACTH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective comparison of DOTA, DOPA, and conventional imaging modalities in EAS was conducted at a tertiary referral center. Participants included 24 patients with EAS from neuroendocrine tumors confirmed by pathology and\/or biochemical cure. Interventions included DOTA PET\/CT, DOPA PET\/CT, CT, MRI, gated cardiac CT\/MRI, and Octreoscan (OCT) performed between 2014 and 2024. Main outcome measures included sensitivity (Se) and positive predictive value (PPV) for each imaging modality, and 7 combinations thereof, in patients with identified tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of functional scans, Se for DOPA was higher than OCT (Se 88%; 95% CI, 67%-97% vs 31%; 95% CI, 10%-61%) and overlapped DOTA (Se 79%; 95% CI, 57%-92%). Among structural modalities, CT had the highest Se (96%; 95% CI, 76%-100%) when interpreted knowing results of functional scans; Se was 57% (95% CI, 35%-76%) without those data. Cardiac CT\/MRI had the highest PPV (100% for each). Combinations of CT\/MRI plus DOTA and\/or DOPA provided high PPVs (89%-100%) with Se 64% to 87%; all CIs overlapped. Combined CT and MRI without functional scans provided PPV 79% with Se 55%, although CI overlapped with combinations that included DOTA\/DOPA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DOTA and DOPA improve tumor detection in EAS by increasing Se of structural scans and PPV of detected lesions. The two scans are complementary and should be integral to imaging strategies for EAS. However, DOPA is not currently approved by the Food and Drug Administration for this indication.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf114","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:51:06Z","timestamp":1740642666000},"page":"e3794-e3802","source":"Crossref","is-referenced-by-count":6,"title":["Prospective Evaluation of 68Ga-DOTATATE and 18F-DOPA PET Scans in Detecting Tumors Causing Ectopic ACTH Syndrome"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6876-9762","authenticated-orcid":false,"given":"Henrik","family":"Elenius","sequence":"first","affiliation":[{"name":"Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-9232","authenticated-orcid":false,"given":"Raven","family":"McGlotten","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-1434","authenticated-orcid":false,"given":"Chuong D","family":"Hoang","sequence":"additional","affiliation":[{"name":"Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-7375","authenticated-orcid":false,"given":"Clara C","family":"Chen","sequence":"additional","affiliation":[{"name":"Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3035-093X","authenticated-orcid":false,"given":"Corina","family":"Millo","sequence":"additional","affiliation":[{"name":"Department of Positron Emission Tomography, National Institutes of Health Clinical Center, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2476-481X","authenticated-orcid":false,"given":"Ahmed M","family":"Gharib","sequence":"additional","affiliation":[{"name":"Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-8025","authenticated-orcid":false,"given":"Lynnette K","family":"Nieman","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"5","key":"2025101519582248100_dgaf114-B1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing's syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025101519582248100_dgaf114-B2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12020-019-02098-2","article-title":"(68)Ga-DOTATOC PET\/CT in detecting neuroendocrine tumours responsible for initial or recurrent paraneoplastic Cushing's syndrome","volume":"67","author":"Belissant Benesty","year":"2020","journal-title":"Endocrine"},{"issue":"4","key":"2025101519582248100_dgaf114-B3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-16-0809","article-title":"Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study","volume":"176","author":"Davi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025101519582248100_dgaf114-B4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2018.01.005","article-title":"The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging","volume":"47","author":"Hayes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"2025101519582248100_dgaf114-B5","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/JC.2015-1589","article-title":"Conventional and nuclear medicine imaging in ectopic Cushing's syndrome: a systematic review","volume":"100","author":"Isidori","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025101519582248100_dgaf114-B6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EC-20-0089","article-title":"The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome","volume":"9","author":"Ceccato","year":"2020","journal-title":"Endocr Connect"},{"issue":"2","key":"2025101519582248100_dgaf114-B7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/EC-16-0010","article-title":"Comparison of 68Ga-DOTANOC PET\/CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome","volume":"5","author":"Goroshi","year":"2016","journal-title":"Endocr Connect"},{"issue":"8","key":"2025101519582248100_dgaf114-B8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.arcmed.2006.05.015","article-title":"Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor","volume":"37","author":"Hernandez","year":"2006","journal-title":"Arch Med Res"},{"issue":"8","key":"2025101519582248100_dgaf114-B9","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101519582248100_dgaf114-B10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025101519582248100_dgaf114-B11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025101519582248100_dgaf114-B12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/jcem.84.4.5576","article-title":"Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients","volume":"84","author":"Torpy","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101519582248100_dgaf114-B13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cen.14008","article-title":"The clinical impact of [(68) Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone\u2014secreting tumours","volume":"91","author":"Wannachalee","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2025101519582248100_dgaf114-B14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ando.2024.07.001","article-title":"Diagnostic performance of various imaging modalities in localizing ectopic ACTH syndrome: a systematic review","volume":"85","author":"Channaiah","year":"2024","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2025101519582248100_dgaf114-B15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000526167","article-title":"Diagnostic strategy and prognostic factors for ectopic adrenocorticotropic hormone syndrome: a retrospective study of 64 cases","volume":"113","author":"Chen","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"11","key":"2025101519582248100_dgaf114-B16","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/clinem\/dgae258","article-title":"Personalized noninvasive diagnostic algorithms based on urinary free cortisol in ACTH-dependant Cushing's syndrome","volume":"109","author":"Lavoillotte","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025101519582248100_dgaf114-B17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","article-title":"The ectopic ACTH syndrome","volume":"11","author":"Alexandraki","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"2025101519582248100_dgaf114-B18","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2025101519582248100_dgaf114-B19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13244-024-01775-9","article-title":"Differentiating lung neuroendocrine neoplasms from tumor-like infection using CT in patients with ectopic ACTH syndrome","volume":"15","author":"Song","year":"2024","journal-title":"Insights Imaging"},{"key":"2025101519582248100_dgaf114-B20","doi-asserted-by":"crossref","first-page":"1204963","DOI":"10.3389\/fonc.2023.1204963","article-title":"Site-specific performance of (68)Ga-DOTATATE PET\/CT in detecting tumors with ectopic adrenocorticotropic hormone secretion","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"2025101519582248100_dgaf114-B21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/cen.12313","article-title":"(68) Ga- DOTA(0) -Tyr(3) octreotide (DOTATOC) positron emission tomography (PET)\/CT in five cases of ectopic adrenocorticotropin-secreting tumours","volume":"81","author":"Gilardi","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2025101519582248100_dgaf114-B22","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/jc.2009-2282","article-title":"Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors","volume":"95","author":"Zemskova","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025101519582248100_dgaf114-B23","doi-asserted-by":"crossref","first-page":"e14769","DOI":"10.1097\/MD.0000000000014769","article-title":"The utility of 18F-FDG and 68Ga-DOTA-peptide PET\/CT in the evaluation of primary pulmonary carcinoid: a systematic review and meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2025101519582248100_dgaf114-B24","doi-asserted-by":"crossref","first-page":"101513","DOI":"10.1016\/j.beem.2021.101513","article-title":"New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome","volume":"35","author":"Senanayake","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2025101519582248100_dgaf114-B25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen.13745","article-title":"Prospective evaluation of (68) Ga-DOTATATE PET\/CT in limited disease neuroendocrine tumours and\/or elevated serum neuroendocrine biomarkers","volume":"89","author":"Gabriel","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2025101519582248100_dgaf114-B26","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2025101519582248100_dgaf114-B27","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1161\/01.CIR.102.21.2582","article-title":"Noninvasive coronary vessel wall and plaque imaging with magnetic resonance imaging","volume":"102","author":"Botnar","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"2025101519582248100_dgaf114-B28","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing's syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf114\/62206995\/dgaf114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3794\/62206995\/dgaf114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/11\/e3794\/62206995\/dgaf114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:58:33Z","timestamp":1760572713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/11\/e3794\/8046291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,2,28]]},"published-print":{"date-parts":[[2025,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf114","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,2,28]]}}}